Apollo Endosurgery Stock Soars on Buyout Buzz

APEN hit a one-year high after the news broke

Laura McCandless

Deputy Editor

Nov 29, 2022 at 10:50 AM

BSX
APEN

Apollo Endosurgery Inc (NASDAQ:APEN) stock is soaring, up 63.4% at $9.80 at last glance, after news that Boston Scientific Corp (BSX) will acquire the medical equipment name for $417 million. The deal, which is expected to close in the first half of 2023, is valued at roughly $615 million including debt, and will expand BSX's portfolio of gastric devices.

Today's pop has APEN trading at fresh one-year highs, as well as gapping well above its 320-day moving average. A short-term bounce was already in the cards, too, as the stock's 14-day relative strength index (RSI) of 29.5 stands in "oversold" territory. Year-to-date, the equity is now up 17.1%.

APEN's options volume is typically nonexistent, making the 1,935 calls exchanged so far much more notable. The December 10 call accounts for most of this activity, with positions being opened there.

Analysts are firmly bullish on Apollo Endosurgery stock. All three firms in coverage carry a "strong buy" rating, while the 12-month consensus price target of $12.60 is a hefty 27.5% premium to current levels.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.